Stay updated with breaking news from Precigen inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Magnolia Capital Advisors LLC purchased a new stake in shares of Precigen, Inc. (NASDAQ:PGEN – Free Report) during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund purchased 39,997 shares of the biotechnology company’s stock, valued at approximately $57,000. Other large investors have also recently bought and […] ....
Magnolia Capital Advisors LLC purchased a new position in shares of Precigen, Inc. (NASDAQ:PGEN – Free Report) in the third quarter, Holdings Channel.com reports. The institutional investor purchased 39,997 shares of the biotechnology company’s stock, valued at approximately $57,000. Other hedge funds also recently added to or reduced their stakes in the company. Emfo LLC […] ....
/PRNewswire/ DelveInsight s CAR T-Cell Therapy Market Insights report includes a comprehensive understanding of current treatment practices, emerging CAR. ....
DelveInsight Business Research, LLP: CAR T-Cell Therapy Market to Register Stunning Growth During the Study Period (2019-2032) finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Precigen (PGEN) Granted FDA Orphan Drug Designation for PRGN-2012 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.